» Articles » PMID: 35232816

The Key Features of SARS-CoV-2 Leader and NSP1 Required for Viral Escape of NSP1-mediated Repression

Overview
Journal RNA
Specialty Molecular Biology
Date 2022 Mar 2
PMID 35232816
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2, responsible for the ongoing global pandemic, must overcome a conundrum faced by all viruses. To achieve its own replication and spread, it simultaneously depends on and subverts cellular mechanisms. At the early stage of infection, SARS-CoV-2 expresses the viral nonstructural protein 1 (NSP1), which inhibits host translation by blocking the mRNA entry tunnel on the ribosome; this interferes with the binding of cellular mRNAs to the ribosome. Viral mRNAs, on the other hand, overcome this blockade. We show that NSP1 enhances expression of mRNAs containing the SARS-CoV-2 leader. The first stem-loop (SL1) in the viral leader is both necessary and sufficient for this enhancement mechanism. Our analysis pinpoints specific residues within SL1 (three cytosine residues at the positions 15, 19, and 20) and another within NSP1 (R124), which are required for viral evasion, and thus might present promising drug targets. We target SL1 with the antisense oligo (ASO) to efficiently and specifically down-regulate SARS-CoV-2 mRNA. Additionally, we carried out analysis of a functional interactome of NSP1 using BioID and identified components of antiviral defense pathways. Our analysis therefore suggests a mechanism by which NSP1 inhibits the expression of host genes while enhancing that of viral RNA. This analysis helps reconcile conflicting reports in the literature regarding the mechanisms by which the virus avoids NSP1 silencing.

Citing Articles

A Comparison of Conserved Features in the Human Coronavirus Family Shows That Studies of Viruses Less Pathogenic than SARS-CoV-2, Such as HCoV-OC43, Are Good Model Systems for Elucidating Basic Mechanisms of Infection and Replication in Standard....

Heffner A, Rouault T Viruses. 2025; 17(2).

PMID: 40007010 PMC: 11860170. DOI: 10.3390/v17020256.


The transcriptional and translational landscape of HCoV-OC43 infection.

Bresson S, Sani E, Armatowska A, Dixon C, Tollervey D PLoS Pathog. 2025; 21(1):e1012831.

PMID: 39869630 PMC: 11771880. DOI: 10.1371/journal.ppat.1012831.


Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA.

Sakai A, Singh G, Khoshbakht M, Bittner S, Lohr C, Diaz-Tapia R Mol Ther Nucleic Acids. 2024; 35(4):102331.

PMID: 39376996 PMC: 11456799. DOI: 10.1016/j.omtn.2024.102331.


Comprehensive Profiling of Roquin Binding Preferences for RNA Stem-Loops.

Oberstrass L, Tants J, Lichtenthaeler C, Ali S, Koch L, Mathews D Angew Chem Int Ed Engl. 2024; 63(50):e202412596.

PMID: 39344866 PMC: 11609897. DOI: 10.1002/anie.202412596.


The emerging role of SARS-CoV-2 nonstructural protein 1 (nsp1) in epigenetic regulation of host gene expression.

Ivanov K, Yang H, Sun R, Li C, Guo D FEMS Microbiol Rev. 2024; 48(5).

PMID: 39231808 PMC: 11418652. DOI: 10.1093/femsre/fuae023.


References
1.
Lee K, Chen C, Shih S . Regulation Mechanisms of Viral IRES-Driven Translation. Trends Microbiol. 2017; 25(7):546-561. DOI: 10.1016/j.tim.2017.01.010. View

2.
Zhang K, Miorin L, Makio T, Dehghan I, Gao S, Xie Y . Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression. Sci Adv. 2021; 7(6). PMC: 7864571. DOI: 10.1126/sciadv.abe7386. View

3.
Lebreton A, Tomecki R, Dziembowski A, Seraphin B . Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature. 2008; 456(7224):993-6. DOI: 10.1038/nature07480. View

4.
Tummers B, Goedemans R, Pelascini L, Jordanova E, van Esch E, Meyers C . The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation. Nat Commun. 2015; 6:6537. PMC: 4382698. DOI: 10.1038/ncomms7537. View

5.
Olsen J, de Godoy L, Li G, Macek B, Mortensen P, Pesch R . Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics. 2005; 4(12):2010-21. DOI: 10.1074/mcp.T500030-MCP200. View